Mirum Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Mirum Pharmaceuticals, Inc. (MIRM) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -58.94% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-02-25
- Mirum Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2025 was -58.94%.
- Mirum Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -7.50%.
- Mirum Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -1.91%.
- Mirum Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -4.96%, a 164.25% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 8 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -58.94% 10-K · filed 2026-02-25 | ||
| 2024-12-31 | -7.50% 10-K · filed 2026-02-25 | ||
| 2023-12-31 | -1.91% 10-K · filed 2026-02-25 | 1.91% 10-K · filed 2024-03-15 | |
| 2022-12-31 | -4.96% 10-K · filed 2025-02-26 | 4.96% 10-K · filed 2023-03-08 | |
| 2021-12-31 | 7.72% 10-K · filed 2024-03-15 | ||
| 2020-12-31 | 6.42% 10-K · filed 2022-03-09 | ||
| 2019-12-31 | 7.32% 10-K · filed 2021-03-09 | ||
| 2018-12-31 | 1.94% 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |